GE HealthCare Technologies Accounts Receivable decreased by 4.3% to $3.79B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $3.57B to $3.79B. Over 2 years (FY 2022 to FY 2025), Accounts Receivable shows an upward trend with a 9.6% CAGR.
An increase relative to sales may signal slowing collections or credit risk, while a decrease suggests efficient cash conversion.
The total amount of credit extended to customers and channel partners for products sold or services rendered, minus an a...
Typically scales with revenue growth; however, companies with strong direct-to-consumer channels may have lower receivables relative to those relying on third-party distributors.
accounts_receivable_net| Q4 '22 | Q1 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $3.30B | $3.37B | $3.57B | $3.57B | $3.56B | $3.73B | $3.96B | $3.79B |
| QoQ Change | — | +2.4% | +5.7% | +0.2% | -0.3% | +4.8% | +5.9% | -4.3% |
| YoY Change | — | — | — | — | — | — | +10.9% | +6.0% |